Jim Simons Co Diagnostics, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 550,322 shares of CODX stock, worth $137,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares

550,322

Previous 555,622 0.95%

Holding current value

$137,580

Previous $416,000 59.13%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.31 - $1.0 $1,643 - $5,300	-5,300 Reduced 0.95%	550,322 $170,000
Q4 2024 Feb 13, 2025	SELL	$0.7 - $1.36 $8,470 - $16,456	-12,100 Reduced 2.13%	555,622 $416,000
Q3 2024 Nov 13, 2024	SELL	$1.02 - $1.75 $19,663 - $33,736	-19,278 Reduced 3.28%	567,722 $709,000
Q2 2024 Aug 09, 2024	SELL	$1.01 - $1.7 $13,534 - $22,780	-13,400 Reduced 2.23%	587,000 $733,000
Q1 2024 May 13, 2024	SELL	$1.06 - $1.42 $17,596 - $23,572	-16,600 Reduced 2.69%	600,400 $672,000
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.5 $19,400 - $29,100	-19,400 Reduced 3.05%	617,000 $821,000
Q3 2023 Nov 14, 2023	SELL	$1.03 - $1.85 $17,819 - $32,005	-17,300 Reduced 2.65%	636,400 $675,000
Q2 2023 Aug 11, 2023	BUY	$1.04 - $1.64 $5,616 - $8,856	5,400 Added 0.83%	653,700 $726,000
Q1 2023 May 12, 2023	SELL	$1.39 - $3.24 $8,201 - $19,116	-5,900 Reduced 0.9%	648,300 $959,000
Q4 2022 Feb 13, 2023	SELL	$2.32 - $3.68 $117,391 - $186,208	-50,600 Reduced 7.18%	654,200 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$2.87 - $7.01 $61,131 - $149,313	21,300 Added 3.12%	704,800 $2.26 Million
Q2 2022 Aug 12, 2022	BUY	$3.76 - $6.29 $366,404 - $612,947	97,448 Added 16.63%	683,500 $3.83 Million
Q1 2022 May 13, 2022	BUY	$5.03 - $9.61 $1.47 Million - $2.8 Million	291,552 Added 99.0%	586,052 $3.62 Million
Q4 2021 Feb 11, 2022	BUY	$8.12 - $10.37 $893,199 - $1.14 Million	110,000 Added 59.62%	294,500 $2.63 Million
Q3 2021 Nov 12, 2021	BUY	$7.48 - $11.38 $921,536 - $1.4 Million	123,200 Added 200.98%	184,500 $1.8 Million
Q2 2021 Aug 13, 2021	BUY	$7.16 - $9.56 $438,908 - $586,028	61,300 New	61,300 $506,000
Q1 2020 May 14, 2020	SELL	$0.91 - $17.81 $14,575 - $285,262	-16,017 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.88 - $1.12 $14,094 - $17,939	16,017 New	16,017 $14,000

Others Institutions Holding CODX

# of Institutions

Shares Held

5.73M

Call Options Held

35.6K

Put Options Held

25.9K

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $8.45M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account